Drreddys Laboratories | RDY - Net Income


Drreddys Laboratories reported INR12.1B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
ANI Pharmaceuticals USD 29.49M 2.86M Mar/2026
Aurora Cannabis CAD 1.82M 53.29M Dec/2025
Bayer EUR 2.76B 6.52B Mar/2026
Canopy Growth CAD -62.63M 60.99M Dec/2025
Cipla INR 5.55B 1.21B Mar/2026
Corcept Therapeutics USD -31.76M 56.05M Mar/2026
Drreddys Laboratories INR 12.1B 2.08B Dec/2025
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Lonza CHF 426M 119M Jun/2025
Novartis USD 3.16B 747M Mar/2026
Pacira USD 2.92M 1.28M Mar/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Richter Gedeon HUF 65.28B 21.94B Mar/2026
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Supernus Pharmaceuticals USD -2.29M 1.81M Mar/2026
Teva Pharmaceutical Industries USD 369M 111M Mar/2026